SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-019433
Filing Date
2017-04-06
Accepted
2017-04-06 16:31:02
Documents
12
Period of Report
2017-05-17
Effectiveness Date
2017-04-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A v463111_def14a.htm DEF 14A 1039543
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_anipharma-black.jpg GRAPHIC 22979
4 GRAPHIC sig_stephen-carey.jpg GRAPHIC 18593
5 GRAPHIC spacer.gif GRAPHIC 43
6 GRAPHIC sig_arthur-przybyl.jpg GRAPHIC 31284
7 GRAPHIC v463111_prxycard-1.jpg GRAPHIC 375344
8 GRAPHIC v463111_prxycard-2.jpg GRAPHIC 608489
9 GRAPHIC v463111_prxycard-3.jpg GRAPHIC 256275
10 GRAPHIC v463111_prxycard-4.jpg GRAPHIC 60936
11 GRAPHIC v463111_prxycard-5.jpg GRAPHIC 727161
12 GRAPHIC v463111_prxycard-6.jpg GRAPHIC 594317
  Complete submission text file 0001144204-17-019433.txt   4753011
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31812 | Film No.: 17746387
SIC: 2834 Pharmaceutical Preparations